Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Giripladib (PLA695)(PLX-695) is a cPLA2-specific inhibitor that inhibits the radiation-induced increase of phosphorylated ERK and phosphorylated Akt in endothelial cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 448.00 | |
10 mg | In stock | $ 658.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,380.00 | |
100 mg | In stock | $ 1,890.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 656.00 |
Description | Giripladib (PLA695)(PLX-695) is a cPLA2-specific inhibitor that inhibits the radiation-induced increase of phosphorylated ERK and phosphorylated Akt in endothelial cells. |
Synonyms | PLA 695, PLA-695, PLA695 |
Molecular Weight | 745.25 |
Formula | C41H36ClF3N2O4S |
CAS No. | 865200-20-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.45 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Giripladib 865200-20-0 Metabolism Phospholipase PLA 695 PLA-695 PLA695 inhibitor inhibit